RE:RE:RE:RE:A Mickey Mouse Deal / CoQ10 Deal?Tencents wrote: Seems not a bad offer to have a small royalty in a 40 billion market - trying to be too big is risky
bellus sold out to Gsk recently and picked up 2 billion rather than trying to go alone
CZO has lots of options on what to do. As per their Q3 report, a mere 2 weeks before their merger, it stated they were in solid financial condiition to execute their business plan.
Recall that interested parties wanted to licence application catergories of PGX but Gilles held out for individual chemical complexes. Avalyn raised $175M USD for their IPF pipeline, no doubt PGX Y-BG could raise funds or partner up to accelerate its development. When you consider that CZO said they wanted to set up a protocol for a phase 1 study by end of 2020, it's another example of a failure to meet deadlines / execute with any sense of urgency.
When a special committee is formed, most companies will announce the purpose of why and publicly release a statement to shareholders. We the so called "valued" shareholders are told nothing at that time.We were just told long ago they wanted to uplist onto NASDAQ and Gilles stated that would require a tremendous ratio for a rollback and that was not desirable. But alas, guaranteeing himself a CEO postion at AEZS again and avoiding getting the boot from CZO is of course self serving.